Recruiting Watch

Legal News - LexBlogosphere: 4/30/08

kevin.lexblog.com0 comments

Here we are, at the doorstep of another month with another batch of legal updates. It’s the usual game plan this afternoon: ten posts, from Austin to Miami and back again, covering diverse issues from across the legal…

Merck, Singulair and FDA : Bio Job Blog

biojobblog.com2 comments

After weathering the Vioxx storm for the past three years, Merck again finds itself in choppy and unchartered waters. Still reeling from the Vytorin flap that erupted two months ago, there are new allegations that its…

Covered by:kevin.lexblog.com

About : Bio Job Blog

biojobblog.com0 comments

Covered by:kevin.lexblog.com

The Top 10 Interview Questions That You Hate to Answer! : Bio Job Blog

biojobblog.com0 comments

During the course of my 25 years or so of participating in job interviews, I have come across a variety of questions that interviewers seem to routinely ask interviewees. While some of the questions may seem silly or…

Covered by:kevin.lexblog.com

Pfizer Proves That Biggest Is Not Always Best

biojobblog.com0 comments

Pfizer the world’s largest and least innovative pharmaceutical company  announced yesterday that its profits dropped by 18% last year. The company attributed the loss to reductions in the sale of its blockbuster…

Covered by:kevin.lexblog.com

FDA Advisory Panel Gives a “Thumbs Up” To Continue Using EPO for Cancer Patients

biojobblog.com0 comments

According to Johnson & Johnson, a panel of advisors for the Food and Drug Administration, in a surprise decision, supported keeping Epogen, Procrit and Aranesp from Amgen and Johnson & Johnson on the market for…

Covered by:kevin.lexblog.com